Clinical trial
A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia
NCT00001991 · Glaxo Wellcome, Industry · Completed
Key facts
| NCT number | NCT00001991 |
|---|---|
| Title | A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia |
| Official title | A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia |
| Lead sponsor | Glaxo Wellcome, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Pneumonia, Pneumocystis Carinii, HIV Infections |
| Intervention type | Drug |
| Interventions | Atovaquone |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: